Research suggests that a protein called FMRP is involved in regulating a shift in the function and expression of GABABR that is dependent on ethanol and has rapid antidepressant properties. This finding may have implications for understanding neurological disorders. The role of GABAergic signaling in these disorders is being explored, with some studies indicating a paradoxical switch from inhibitory to excitatory signaling.